Program: Thursday, May 10, 2012

Introduction and Welcome
Nancy E. Davidson, MD

Julene Fabrizio Keynote Lecture: 40 Years of Ovarian Cancer Research
Nelly Auersperg, MD, PhD

Epidemiologic and Genetic Factors

New Insights into the Endometriosis – Ovarian Cancer Link
C. Leigh Pearce, PhD

Inherited Factors in Ovarian Cancer
Ellen L. Goode, PhD

Immunosuppression Pathways in Ovarian Cancer
Kirsten B. Moysich, PhD, MS

Panel Discussion
Moderator: Annekatrin Lukanova-McGregor, MD, PhD

Prevention, Early Detection and Biomarkers

Biomarkers for Management of Ovarian Cancer
Robert C. Bast Jr., MD

Proteomic Analysis of Pelvic Tissues Collected During Risk-Reducing: Surgery in BRCA Mutation Carriers 
Kristin K. Zorn, MD

Impact of the New Paradigm on the Treatment of High Risk Women
Marian J. Mourits, MD

Panel Discussion
Moderator: Paul Pinskey, PhD

Comment on Ovarian Cancer Screening
Nancy E. Davidson, MD

Ovarian Cancer Biology – Mechanisms and Targets

MicroRNAs Work Together with RNA-binding Proteins in Ovarian Cancer
Setsuko K. Chambers, MD

Mechanisms of Psychological Stress on the Adaptive Immune System
Melanie S. Flint, MSc, PhD

Panel Discussion
Moderator: Donald J. Buchsbaum, PhD

New Directions in Therapeutics and Prevention 1

Prostaglandin E2 in Ovarian Cancer-Associated Immune Dysfunction
Pawel Kalinski, MD, PhD

Molecular Mechanisms of Tumor Antigens and Vaccine Therapies
Kunle Odunsi, MD, PhD

Inhibiting Cancer Stem Cells
Patricia K. Donahoe, MD

Panel Discussion
Moderator: Alexander Olawaiye, MD

The CDMRP Department of Defense Ovarian Cancer Academy

Karen Wylie

Preclinical Modeling of Ovarian Cancer and Other Gynecologic Malignancies: Disease Pathogenesis and Vaccine Development
Anda Vlad, MD, PhD

Ovarian Cancer Stem Cells: Clinically Significant or Experimental Phenomenon?
Charles Landen, MD

Tumor Heterogeneity: Understanding Etiologic Risk Factors
Kathryn Terry, ScD

Association of BRCAness Profile with Outcome and Molecular Aberrations Involving Homologous Recombination in the TCGA Ovarian Cancer Dataset
Panagiotis Konstantinopoulos, MD, PhD

Wnt Signaling, Cellular Senescence and Ovarian Cancer Therapy
Rugang Zhang, PhD

Integrative Approaches to Care Educational Series
Cooper Auditorium, Hillman Cancer Center
In Memory of Julene Fabrizio

Program: Thursday, May 10, 2012

Introduction and Welcome
Mary Urban, NOCC

Complementary Care

Combining Complementary Approaches with Standard Care
Joy Sakonyi, ND

The Role of Traditional Healing Systems in Cancer Care
Judith L. Balk, MD, MPH

The Anti-Cancer Diet: Eat to Live a Longer Life
Julia Greer, MD, MPH 
Nb: Dr. Greer’s presentation was delivered by Dr. Balk

Panel Discussion
Moderator: Mary Urban, NOCC

Advocacy and Family Support

Ovarian Cancer is More Than a Woman’s Disease
David Barley, MBA

Getting the Most from Your Doctor Visit
Winifred Tueteberg, MD

Cancer and Depression: A Family Affair
Stephanie Samolovitch, MSW, LSW
Bonnie Shields, MSW, LSW

Panel Discussion
Mary Urban, NOCC


Living With, Through and Beyond Cancer
Diane C. Bodurka, MD

We thank the National Ovarian Cancer Coalition and Magee-Womens Hospital for their support of this educational session.

Program: Friday, May 11, 2012

Ann O’Mara, PhD, RN, FAAN

Plenary Talk – Karen A. Johnson Memorial: Creating Effective Patient – Physician Partnerships
Martha E. Gaines, JD

Innovative Approaches to Symptoms Assessment and Management

Biobehavioral Models for Symptom Management
Dana H. Bovbjerg, PhD

Using Patient Reported Outcomes to Measure Therapeutic Response and Toxicities in Clinical Trials
Sandra A. Mitchell, PhD, CRNP

Novel Approaches to Symptom Management Research
Heidi S. Donovan, PhD, RN

Panel Discussion
Ann O’Mara, PhD, RN, FAAN

Comment on Prioritizing Symptoms
Heidi S. Donovan, PhD, RN

Morris & Carolyn Barkon Lectureship in Gynecologic Oncology Survivorship

Gynecologic Cancer Survivors: Challenges and Innovations
Diane C. Bodurka, MD

New Directions in Therapeutics and Prevention 2

Phenotypic Probing of the Mononuclear Phagocyte System as a Method to Individualize Therapy in Patients with Refractory Ovarian Cancer
William Zamboni, PharmD, PhD

Genomic Defined Subtype-Specific Cancer Control Opportunities
David G. Huntsman, MD

Ovarian Cancer: Embracing Barriers to Progress
Michael V. Seiden, MD, PhD

Hot Topic: Barriers to Improving Ovarian Cancer Outcome and Survival
Moderator Panelists:
Robert P. Edwards, MD
David Barley, CEO NOCC
Diane C. Bodurka, MD
David G. Huntsman, MD
Anna Lokshin, PhD
Ann O’Mara, PhD, RN, FAAN
Michael Seiden, MD, PhD
William Zamboni, PhD